ImmunoPrecise Antibodies (IPA) Competitors $2.10 +0.17 (+8.55%) Closing price 09/3/2025 07:52 PM EasternExtended Trading$2.10 0.00 (0.00%) As of 09/3/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IPA vs. PRME, CGC, NBTX, CRVS, SLDB, CMPS, UPXI, REPL, PRTC, and INBXShould you be buying ImmunoPrecise Antibodies stock or one of its competitors? The main competitors of ImmunoPrecise Antibodies include Prime Medicine (PRME), Canopy Growth (CGC), Nanobiotix (NBTX), Corvus Pharmaceuticals (CRVS), Solid Biosciences (SLDB), COMPASS Pathways (CMPS), Upexi (UPXI), Replimune Group (REPL), PureTech Health (PRTC), and Inhibrx Biosciences (INBX). These companies are all part of the "pharmaceutical products" industry. ImmunoPrecise Antibodies vs. Its Competitors Prime Medicine Canopy Growth Nanobiotix Corvus Pharmaceuticals Solid Biosciences COMPASS Pathways Upexi Replimune Group PureTech Health Inhibrx Biosciences ImmunoPrecise Antibodies (NASDAQ:IPA) and Prime Medicine (NYSE:PRME) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends. Do institutionals and insiders hold more shares of IPA or PRME? 6.7% of ImmunoPrecise Antibodies shares are owned by institutional investors. Comparatively, 70.4% of Prime Medicine shares are owned by institutional investors. 6.8% of ImmunoPrecise Antibodies shares are owned by insiders. Comparatively, 22.7% of Prime Medicine shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is IPA or PRME more profitable? Prime Medicine has a net margin of 0.00% compared to ImmunoPrecise Antibodies' net margin of -122.10%. ImmunoPrecise Antibodies' return on equity of -40.62% beat Prime Medicine's return on equity.Company Net Margins Return on Equity Return on Assets ImmunoPrecise Antibodies-122.10% -40.62% -22.19% Prime Medicine N/A -107.87%-74.97% Which has higher earnings and valuation, IPA or PRME? ImmunoPrecise Antibodies has higher revenue and earnings than Prime Medicine. ImmunoPrecise Antibodies is trading at a lower price-to-earnings ratio than Prime Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunoPrecise Antibodies$17.59M5.50-$21.69M-$0.68-3.08Prime Medicine$4.96M100.91-$198.13M-$1.56-2.38 Do analysts rate IPA or PRME? ImmunoPrecise Antibodies presently has a consensus price target of $4.00, indicating a potential upside of 90.93%. Prime Medicine has a consensus price target of $8.92, indicating a potential upside of 139.70%. Given Prime Medicine's higher probable upside, analysts plainly believe Prime Medicine is more favorable than ImmunoPrecise Antibodies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ImmunoPrecise Antibodies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Prime Medicine 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75 Which has more volatility and risk, IPA or PRME? ImmunoPrecise Antibodies has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Comparatively, Prime Medicine has a beta of 2.38, suggesting that its share price is 138% more volatile than the S&P 500. Does the media favor IPA or PRME? In the previous week, ImmunoPrecise Antibodies and ImmunoPrecise Antibodies both had 3 articles in the media. ImmunoPrecise Antibodies' average media sentiment score of 0.33 beat Prime Medicine's score of 0.15 indicating that ImmunoPrecise Antibodies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ImmunoPrecise Antibodies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Prime Medicine 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryPrime Medicine beats ImmunoPrecise Antibodies on 9 of the 16 factors compared between the two stocks. Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IPA vs. The Competition Export to ExcelMetricImmunoPrecise AntibodiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$96.68M$2.09B$5.76B$9.91BDividend YieldN/AN/A6.71%4.52%P/E Ratio-3.0838.2075.5426.08Price / Sales5.509.34480.4288.28Price / CashN/A52.8536.9659.01Price / Book5.6611.1511.446.09Net Income-$21.69M-$63.67M$3.28B$266.14M7 Day Performance-11.60%-1.25%0.96%0.44%1 Month Performance10.85%6.08%7.83%4.55%1 Year Performance212.92%37.17%62.65%26.15% ImmunoPrecise Antibodies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IPAImmunoPrecise Antibodies2.4657 of 5 stars$2.10+8.5%$4.00+90.9%+212.7%$96.68M$17.59M-3.0880Short Interest ↓Gap UpPRMEPrime Medicine3.3104 of 5 stars$3.24-5.8%$8.92+175.2%-0.8%$436.02M$4.96M-1.58234CGCCanopy Growth1.1649 of 5 stars$1.80-4.3%N/A-69.2%$431.73M$225.65M-0.593,150Positive NewsShort Interest ↓NBTXNanobiotix0.4044 of 5 stars$8.94-3.2%$8.00-10.5%+59.4%$428.85M$39.18M0.00100News CoveragePositive NewsGap DownCRVSCorvus Pharmaceuticals2.3571 of 5 stars$5.74+6.1%$15.00+161.3%+54.0%$427.71MN/A-5.6830Positive NewsSLDBSolid Biosciences3.3027 of 5 stars$5.48-2.5%$15.00+173.7%-35.4%$426.72M$8.09M-1.96100News CoveragePositive NewsCMPSCOMPASS Pathways2.7367 of 5 stars$4.42-8.1%$16.29+268.5%-23.6%$424.06MN/A-2.40120Positive NewsUPXIUpexi2.5787 of 5 stars$7.23-10.6%$15.50+114.4%+48.4%$423.77M$26M0.00130REPLReplimune Group3.6668 of 5 stars$5.40+0.4%$6.50+20.4%-41.0%$421.50MN/A-1.67210PRTCPureTech Health1.9085 of 5 stars$17.07-1.6%$45.00+163.6%-25.2%$411.93M$4.83M0.00100Short Interest ↑Gap DownINBXInhibrx Biosciences1.2916 of 5 stars$28.20+1.1%N/A+75.7%$408.49M$200K-2.67166Positive News Related Companies and Tools Related Companies Prime Medicine Alternatives Canopy Growth Alternatives Nanobiotix Alternatives Corvus Pharmaceuticals Alternatives Solid Biosciences Alternatives COMPASS Pathways Alternatives Upexi Alternatives Replimune Group Alternatives PureTech Health Alternatives Inhibrx Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IPA) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersThe Altcoin That Could be Poised to Benefit Most from Trump’s ReturnWith Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And ac...Weiss Ratings | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPA Stock Alerts